Cybin IRL Limited

3 trials 1 recruiting Commercial sponsor

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

1 Completed trials

6 Countries active

1 Unique IMPs

100% Results reported

Phase III

Phase I (Other)

Phase III: 2 Phase I (Other): 1

100%

1 of 1 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

DEUPSILOCIN BESILATE 2

All trials

3 total

Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND) Pending

2024-516805-22-00 Phase III 5 countries DEUPSILOCIN BESILATE
A Phase 3 Trial to Assess CYB003 in Major Depressive Disorder Recruiting

2024-519270-40-00 Phase III 5 countries DEUPSILOCIN BESILATE
A study to investigate the safety, pharmacodynamics and pharmacokinetics of increasing doses of subcutaneously administered deuterated DMT (… Ended

2023-507409-32-00 Phase I (Other) 1 country

Showing 1–3 of 3 trials

← All sponsors A–Z